Alliance4Life Mini-conference held at Semmelweis University
On 7–8 May 2026, the Alliance4Life Mini-Conference was held, serving as a significant international professional event for the Central and Eastern European research community. Semmelweis University is an active member of the Alliance4Life (A4L) European collaboration, which brings together Central and Eastern European universities and research institutions to strengthen research excellence, innovation, and international knowledge exchange in the fields of life sciences and healthcare. The university contributes to the development of best practices in HR management, participates in the Green Lab Audit programme promoting sustainable research operations, and supports doctoral education, technology transfer, and interinstitutional cooperation through its network of experts. In addition, Semmelweis University takes part in international research projects, regularly engages in A4L professional trainings and events, and hosts 11 international interns within the framework of the A4L Internship Programme.
The two-day event was opened by Vice-Rector Péter Ferdinandy, who introduced Semmelweis University with a special focus on its research, development, and innovation activities. Altogether 27 speakers presented their research findings and professional experiences. The conference sessions and presentations provided a comprehensive overview of the latest advances in life sciences and medical research innovation. Participants attended lectures on topics such as metabolic adaptation to exercise, integrative exercise genomics and molecular biomarkers in sport medicine, the effects of GLP-1 receptor agonists on muscle structure and function, and blood biomarkers as predictors of running performance.
Dedicated sessions focused on big data and innovation in medical research, including medical data analysis, clinical data utilisation, AI in Clinical Sport Sciences and Fitness Prediction, and health industry innovation ecosystems. Further presentations addressed future challenges in pharmacology, including antibiotic stewardship programmes, precision antibiotic therapy based on pharmacokinetic modeling, synergistic effects of fluconazole and cinnamon oil on Candida auris strains, and the impact of spaceflight and microgravity on pharmacokinetics and pharmacodynamics.
On the second day, presentations highlighted current trends in cardiometabolic molecular research, including biomarkers reflecting high-density lipoprotein composition and functional properties, T-cell involvement in hypertrophic cardiomyopathy phenocopy of Fabry patients revealed by spatial and single-cell transcriptomics, and targeting acylcarnitine levels in heart failure therapy. The final session focused on advances in pain management research, covering opioid analgesia, novel opioid peptides with reduced side effects, peripheral antinociceptive effects of opioids, and the role of Glycine Transporter 1 inhibitors in opioid analgesic tolerance.
On Friday, alongside the scientific presentations, focus group discussions were conducted on factors influencing the operation of the innovation ecosystem, providing participants working in innovation with opportunities for in-depth professional dialogue and exchange of experience. Approximately 50 participants attended the conference from nearly ten European countries, further strengthening the international character of the event. The programme provided an inspiring environment for establishing new professional connections and collaborations.
Text: Dr. Balázs Csizmadia; Vice-Rector for Science and Innovation and Business Development Center
Photo: Boglárka Zellei – Semmelweis University
